6533b7d7fe1ef96bd126915e
RESEARCH PRODUCT
Targeting Alzheimer’s disease with multimodal polypeptide-based nanoconjugates
Aroa Duro-castanoInmaculada Conejos-sánchezAna ArmiñánM. C. Blanco-gandíaMarta Rodríguez-ariasJuan R. ViñaV. Herranz-pérezMarta InglésCristina Mas-barguesMaría J. VicentJosé MiñarroJosé Manuel García-verdugoConsuelo Borrássubject
Alzheimer’s disease (AD)Mice TransgenicNanoconjugatesHippocampal formationHippocampusNeuroprotectionAD treatmentMice03 medical and health scienceschemistry.chemical_compound0302 clinical medicineAlzheimer DiseaseBisdemethoxycurcuminAnimalsOlfactory memoryResearch Articles030304 developmental biology0303 health sciencesAmyloid beta-PeptidesMultidisciplinaryPolyglutamatebiologySciAdv r-articlesLife Sciences3. Good healthOlfactory bulbDisease Models AnimalApplied Sciences and Engineeringchemistrybiology.proteinNeuroscience030217 neurology & neurosurgeryNanoconjugatesResearch ArticleNeurotrophindescription
LRP1-targeted St-Cl–polyglutamate conjugates as multivalent neuroprotective/neurotrophic therapeutics for Alzheimer’s disease.
year | journal | country | edition | language |
---|---|---|---|---|
2021-03-26 | Science Advances |